All News and Events

25 March 2026

Event jointly organized by: AVE and St Vincent's Institute of Medical Research

6 January 2026

Please join us for a special Fireside chat on January 6th, 2026

21 May 2025

Event jointly organized by : Institute for Bioengineering of Catalunya (IBEC) and Centre for Genomic Regulation (CRG)

29 January 2026

It's been an incredible year for our community. We've grown to over 800 members from 58 countries, generated more than 7 million variant effect measurements across 700+ genes in human and model organisms, and made real progress toward a Clinical Atlas of Variant Effects.

20 January 2026

Professor Yang Jianrong, a researcher and professor at with Sun Yat-sen University in Guangzhou, China, is a confirmed speaker at the upcoming Ninth Annual Mutational Scanning Symposium, March 25-27, in Melbourne, Australia.

10 November 2025

We aim to strike a balance between theoretical, computational, and experimental approaches to ensure comprehensive coverage of the field.

28 January 2026

How can different molecular measurements enhance our understanding of membrane proteins and the genetic diseases caused by their dysfunction? In this episode, we explain how membrane proteins relay environmental information to cells, focusing on channels that gate ions and molecules.

17 December 2025

How can we use genomic technologies to tackle blood diseases? In this episode, we explain the role of genetic variants in blood disorders and how genomics approaches, such as gene editing can help cure these diseases.

Transcript and show notes can be found here.

30 June 2025

Who do you ask if you have a question about a gene? In this episode, we dive into the teams and scientists that are building an encyclopedia of knowledge about your genes.

Transcript and show notes can be found here.

3 February 2026

Stephan Riesenberg is a German biochemist and genome engineer known for developing practical solutions to some of the most persistent limitations of CRISPR-based technologies. He is a Group Leader at the Max Planck Institute for Evolutionary Anthropology in Leipzig, where he develops molecular strategies to control DNA repair outcomes and enable predictable genome modification for research and biomedical applications. He earned his PhD in Biochemistry and later completed an MD-scientist degree at the University of Leipzig. Riesenberg was trained in...moreStephan Riesenberg is a German biochemist and genome engineer known for developing practical solutions to some of the most persistent limitations of CRISPR-based technologies. He is a Group Leader at the Max Planck Institute for Evolutionary Anthropology in Leipzig, where he develops molecular strategies to control DNA repair outcomes and enable predictable genome modification for research and biomedical applications. He earned his PhD in Biochemistry and later completed an MD-scientist degree at the University of Leipzig. Riesenberg was trained in two Nobel Prize-winning labs. He spent several years at the Max Planck Institute for Evolutionary Anthropology in the lab of Svante Pääbo, awarded the Nobel Prize in Physiology or Medicine in 2022, where he worked at the interface of genome engineering, human evolution, and functional genomics. Earlier, he trained at the University of Copenhagen in the lab of Morten Meldal, recipient of the 2022 Nobel Prize in Chemistry, gaining a strong foundation in chemical biology and protein chemistry. This combination of genetics and chemistry continues to define his technology-driven approach to biology.

3 March 2026

Decoding the TP53 mutational landscape: CRISPR perspectives on functional diversity and therapeutic interventions Julianne Funk is a postdoctoral researcher at the Institute of Molecular Oncology at Marburg University. Her research focuses on functional genomics of the tumor suppressor gene TP53, with a particular emphasis on CRISPR-based saturation genome editing to systematically characterize the effects of cancer-associated variants. Her work aims to improve clinical variant interpretation by linking large-scale functional data with tumor genomics.

3 March 2026

Nisha Kamath obtained her Ph.D. in Pathology/Immunology from Case Western Reserve University under the mentorship of Dr. Kenneth Matreyek. Her thesis project involved using deep mutational scanning and targeted phenotypic assays to understand how variants within the calcium-binding STIM1 cEF-hand domain affect its structure and function. She is currently pursuing a short-term postdoc within the same lab, applying phenotypic assays she developed during her doctoral training to understand the effect of protein variants on genes related to epilepsy.